These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26652841)

  • 21. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
    Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A;
    Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study.
    Harrow M; Jobe TH; Faull RN
    Psychol Med; 2014 Oct; 44(14):3007-16. PubMed ID: 25066792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.
    Tiihonen J; Tanskanen A; Hoti F; Vattulainen P; Taipale H; Mehtälä J; Lähteenvuo M
    Lancet Psychiatry; 2017 Jul; 4(7):547-553. PubMed ID: 28578901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders.
    Pérez-Piñar M; Mathur R; Foguet Q; Ayis S; Robson J; Ayerbe L
    Eur Psychiatry; 2016 May; 35():8-15. PubMed ID: 27061372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antipsychotics: treatment of schizophrenia and other therapeutic options].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10):74-78. PubMed ID: 31793547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
    Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
    Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.
    Vernal DL; Kapoor S; Al-Jadiri A; Sheridan EM; Borenstein Y; Mormando C; David L; Singh S; Seidman AJ; Carbon M; Gerstenberg M; Saito E; Kane JM; Steinhausen HC; Correll CU
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):535-47. PubMed ID: 26375767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotic use and outcomes in an urban maternal mental health service.
    Hatters Friedman S; Moller-Olsen C; Prakash C; North A
    Int J Psychiatry Med; 2016 Aug; 51(6):521-533. PubMed ID: 28629296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of short- and long-term clinical outcome in schizophrenic psychosis--the Northern Finland 1966 Birth Cohort study.
    Juola P; Miettunen J; Veijola J; Isohanni M; Jääskeläinen E
    Eur Psychiatry; 2013 Jun; 28(5):263-8. PubMed ID: 22503721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
    Scala A
    Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254
    [No Abstract]   [Full Text] [Related]  

  • 32. Vitamin D status and correlates of low vitamin D in schizophrenia, other psychoses and non-psychotic depression - The Northern Finland Birth Cohort 1966 study.
    Ikonen H; Palaniswamy S; Nordström T; Järvelin MR; Herzig KH; Jääskeläinen E; Seppälä J; Miettunen J; Sebert S
    Psychiatry Res; 2019 Sep; 279():186-194. PubMed ID: 30876732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic medication and the elderly.
    Raskin DE
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):36-40. PubMed ID: 2859280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotic and Bipolar Disorders: Antipsychotic Drugs.
    Holder SD; Edmunds AL; Morgan S
    FP Essent; 2017 Apr; 455():23-29. PubMed ID: 28437058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual impairment in persons with psychotic disorder.
    Viertiö S; Laitinen A; Perälä J; Saarni SI; Koskinen S; Lönnqvist J; Suvisaari J
    Soc Psychiatry Psychiatr Epidemiol; 2007 Nov; 42(11):902-8. PubMed ID: 17846698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
    J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of treatment-resistant psychoses in the community: A naturalistic study.
    Beck K; McCutcheon R; Stephenson L; Schilderman M; Patel N; Ramsay R; Howes OD
    J Psychopharmacol; 2019 Oct; 33(10):1248-1253. PubMed ID: 31241396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis.
    Jhon M; Yoo T; Lee JY; Kim SY; Kim JM; Shin IS; Williams L; Berk M; Yoon JS; Kim SW
    Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29315805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.